|
Video: What is a Stock Split?
|
|
Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response. According to our DVAX split history records, Dynavax Technologies has had 1 split. | |
|
Dynavax Technologies (DVAX) has 1 split in our DVAX split history database. The split for DVAX took place on November 10, 2014. This was a 1 for 10 reverse split, meaning for each 10 shares of DVAX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Dynavax Technologies conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the DVAX split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Dynavax Technologies shares, starting with a $10,000 purchase of DVAX, presented on a split-history-adjusted basis factoring in the complete DVAX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$15.70 |
|
End price/share: |
$11.17 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-28.85% |
|
Average Annual Total Return: |
-3.35% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,113.10 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
11/10/2014 | 1 for 10 |
|
|